13noBACKGROUND: During the past two decades cryoablation (CA) has become a therapeutic option for the management of localized cT1 renal masses in comorbid patients. We analyzed the midterm functional and oncological outcomes of CA in the treatment of cT1 renal masses which were classified as high-complexity masses according to the PADUA system.METHODS: A total of 299 patients underwent percutaneous CA between November 2007 and December 2018 in 4 institutions for cT1N0M0 renal masses. All patients with highcomplexity (PADUA ≥ 10) renal tumors were included. Technical failure of CA was considered an exclusion criterion.RESULTS: Inclusion criteria were met by 45 patients. Median Charlson Comorbidity Index (CCI) was 6.0 (IQR: 5.0-7.0), median a...
This research topic discusses how safe and effective the use of cryoablation is to treat a renal tum...
Purpose:Cryoablation is done in select patients with pT1b nonmetastatic renal cell carcinoma without...
Objective To analyze our 15-year experience with small renal masses ablation and present oncologic a...
Background and objectives: Cryoablation is emerging as a safe and effective therapeutic option for t...
13noPurpose: To retrospectively investigate long-term outcomes of renal cryoablation from a multicen...
15Introduction & Objectives: To analyze our 10-year experience with Cryoablation (CA) ofSmall Renal ...
Background: Percutaneous cryoablation is a minimally invasive alternative for surgical resection of ...
Purpose: The purpose of the study was to evaluate the safety and efficacy of percutaneous cryoablati...
International audienceOBJECTIVE: To evaluate oncologic and functional outcomes after percutaneous cr...
What\u27s known on the subject? and What does the study add? Given that percutaneous cryoablation (P...
Introduction: Cryoablation (CA) has been broadly used mostly in the treatment of small renal masses ...
11noBackground: Active surveillance (AS) and minimally invasive ablative therapies such as percutane...
10noAim of the study: To report incidence of tumor cell seeding in patients with small renal masses ...
AbstractBackgroundPercutaneous cryoablation is a minimally invasive alternative for surgical resecti...
Introduction: Data regarding long-term oncologic outcomes of laparoscopic renal cryoablation (LRC) a...
This research topic discusses how safe and effective the use of cryoablation is to treat a renal tum...
Purpose:Cryoablation is done in select patients with pT1b nonmetastatic renal cell carcinoma without...
Objective To analyze our 15-year experience with small renal masses ablation and present oncologic a...
Background and objectives: Cryoablation is emerging as a safe and effective therapeutic option for t...
13noPurpose: To retrospectively investigate long-term outcomes of renal cryoablation from a multicen...
15Introduction & Objectives: To analyze our 10-year experience with Cryoablation (CA) ofSmall Renal ...
Background: Percutaneous cryoablation is a minimally invasive alternative for surgical resection of ...
Purpose: The purpose of the study was to evaluate the safety and efficacy of percutaneous cryoablati...
International audienceOBJECTIVE: To evaluate oncologic and functional outcomes after percutaneous cr...
What\u27s known on the subject? and What does the study add? Given that percutaneous cryoablation (P...
Introduction: Cryoablation (CA) has been broadly used mostly in the treatment of small renal masses ...
11noBackground: Active surveillance (AS) and minimally invasive ablative therapies such as percutane...
10noAim of the study: To report incidence of tumor cell seeding in patients with small renal masses ...
AbstractBackgroundPercutaneous cryoablation is a minimally invasive alternative for surgical resecti...
Introduction: Data regarding long-term oncologic outcomes of laparoscopic renal cryoablation (LRC) a...
This research topic discusses how safe and effective the use of cryoablation is to treat a renal tum...
Purpose:Cryoablation is done in select patients with pT1b nonmetastatic renal cell carcinoma without...
Objective To analyze our 15-year experience with small renal masses ablation and present oncologic a...